Commercial

Biomedtracker

Home / products-services / Commercialization / Biomedtracker

Biomedtracker provides analysis of commercial, clinical and regulatory activities as they happen, and present them to you via an easily searchable interface and automated alerts that keep you at the top of your game.

Expert analyst commentary gives context to major market events. What happened? What’s going to happen? Why does it matter and who will it impact?

Our data and analyst insights cut through the noise, so you not only know what happens, but also understand why it matters for your business.

Analyst visualizing the drug development process on screen

See the drug development process through analysts’ eyes

Stay ahead of breaking events, the drugs pipeline, upcoming milestones, companies and deals ― and their impact on the markets you care about.

Are you looking for a needle-in-a-haystack opportunity?
Trying to predict the future of drug approvability and commercial success?
Doing due diligence to evaluate and prioritize potential partnerships or opportunities?

With Biomedtracker, you can:

identify and evaluate in-licensing and out-licensing opportunities that align with your strategic goals
maintain a long-term view of the market to make timely decisions, diversify risk and ensure a steady product line for the long-term
track the market, monitor the landscape and know what’s around the corner

What's included

Market events and catalysts

Access comprehensive event and data tracking, along with a reliable view into future catalysts covering drugs, companies, deals, indications, targets, catalysts, endpoint data, trials, consensus forecasts and product sales.

Multiple perspectives on chances of success

Experience the power of our proprietary LOA and expert analyst commentary on the latest high-impact events combined with the new predictive POA metrics to help rank assets in development.

Deals coverage

View deal summaries, financials and analyst commentary to help you evaluate assets, find partners and prepare deal terms.

Patents and exclusivities

Global patents and US exclusivity coverage provide insight on drug life cycle and potential changes in competitive landscape due to generic entrants.

Comprehensive reports

Pre- and post-conference coverage, topical reports on key disease areas and industry trends and Key Opinion Leader Insights* all provide you with valuable primary research including interviews, surveys and peer-reviewed publications. *Additional subscription required

AdComm insight

Access member profiles, voting history and trends, with commentary from Biomedtracker’s Scientific Analysts to help you better prepare for FDA panel meetings.

Our experts

With more than 500 subject-matter experts in key global markets, Citeline is poised to help life sciences organizations make informed business decisions. Our expertise runs the full gamut of the drug development life cycle, from clinical planning and regulatory to patient engagement and recruitment.

Our solutions and services are backed by skilled developers and analysts who not only aggregate clinical data but understand how it impacts our clients’ business on a daily basis.